Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

Item

http://www.wikidata.org/entity/Q35849045

Q35849045

about

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study A risk prediction score for invasive mold disease in patients with hematological malignancies Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.Caspofungin as secondary antifungal prophylaxis and subsequent maintenance antifungal prophylaxis therapy in hematological malignancy patients.Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?In search of the holy grail of antifungal therapy Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.Updated guidelines for managing fungal diseases in hematology patients.Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients.Acute myeloid leukemia and the infectious diseases consultant.A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report.Prophylaxis of invasive fungal diseases in patients with hematologic disorders Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis.Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients (reply).Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.

P2860

Q33707461-D0A6BA9F-D49C-44F6-9439-22AA86F8B74A Q34166590-A2F85BD1-109D-4D4F-A69A-A330A78E888A Q34532546-6CF8DFFF-72BC-4B6E-B661-FF1FD60C5165 Q34543097-4B3B94A3-9B69-4550-A7A0-70A72907A1B7 Q35005712-FA8B990F-DF02-4A64-B5C4-9D2F3FF05653 Q35821259-7A89C03E-6BBE-4897-B602-715E83DF24EF Q36046991-5E87BA5D-699B-4141-ABA8-92E59F7AC901 Q36431041-A1399B03-1130-40C6-A24E-AE95A3966EA5 Q36443067-1AE77360-1680-480B-BC3E-59E0596C5D34 Q36672181-7DE72133-F8CD-4444-AB1F-59BC016F5041 Q36867435-4DA651DE-B2C1-40A4-9AB4-346B79A8495F Q37650317-2DB87740-DE0F-441E-BD7A-6FBC1ED4C469 Q37711537-6D4DB811-10E2-4A15-AEE7-5650B97944CA Q37785548-EA39C5E0-D282-49D2-B9CE-7D36BE2FD0C5 Q37935599-3AE5259C-E5BE-4765-BB8F-2D3A3777DDDB Q37993110-D842A0C4-BE0F-4691-995E-CE1738752B55 Q38111391-598CB7C4-B6A8-4B3E-95E9-15E3C481669D Q38263489-C8C40CD4-3AA0-481E-8E27-86F37B7359B2 Q40039262-E774E8FA-0120-4D22-9968-7F7B88378A2D Q42222406-6EF6BBD2-033B-456E-A548-253833DCCF75 Q42267015-4FC795DB-9665-4AD1-896C-6516BCAB6EDB Q42415929-534C8824-D10A-4067-8C70-7B3CA411B10E Q42586750-C42C974B-EB57-42C6-9398-8BC4A7463842 Q42970799-64689938-8C1C-4AB8-9F36-E33150D11506 Q45757964-7F070813-EF23-4687-8539-00C3E19D2F91 Q45808812-3707ABFB-7301-4FAF-A37F-17AC9833735A Q46013511-4B979497-CC5F-488E-B4B4-1E16C45C26AA Q46050924-DD4AC9F9-3564-491C-B758-FA0B54B110E0 Q52746966-CC5521E9-D004-41F8-A2A2-EE6790C95EBF

P2860

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

Item

http://www.wikidata.org/entity/Q35849045

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Impact of the intensity of the ...... s Diseases Working Party of th

@ast

Impact of the intensity of the ...... s Diseases Working Party of th

@en

type

Item

label

Impact of the intensity of the ...... s Diseases Working Party of th

@ast

Impact of the intensity of the ...... s Diseases Working Party of th

@en

prefLabel

Impact of the intensity of the ...... s Diseases Working Party of th

@ast

Impact of the intensity of the ...... s Diseases Working Party of th

@en

P1476

Impact of the intensity of the ...... s Diseases Working Party of th

@en

P2093

Aloysius Ho

http://www.w3.org/2001/XMLSchema#string

Ann E Hunter

http://www.w3.org/2001/XMLSchema#string

Anna Nihtinen

http://www.w3.org/2001/XMLSchema#string

Arnold R Zander

http://www.w3.org/2001/XMLSchema#string

Catherine Cordonnier

http://www.w3.org/2001/XMLSchema#string

Dominik Heim

http://www.w3.org/2001/XMLSchema#string

Dominik Selleslag

http://www.w3.org/2001/XMLSchema#string

Ghulam J Mufti

http://www.w3.org/2001/XMLSchema#string

Hans Jürgen Dornbusch

http://www.w3.org/2001/XMLSchema#string

Javier Lopez

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling.

Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.

P304

2928-2936

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-03-008706

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Hermann Einsele

Simone Cesaro

Per Ljungman

P577

2006-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7061550

http://www.w3.org/2001/XMLSchema#string

P698

16720833

http://www.w3.org/2001/XMLSchema#string

P921

aspergillosis

P932

1895522

http://www.w3.org/2001/XMLSchema#string

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

about

P2860

P2860

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932